Work

Characterization of novel potent and selective anaplastic lymphoma kinase (ALK) inhibitors.

Year: 2011

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2011.29.15_suppl.e13600

Authors: C. M. Lovly, E. de Stanchina, H. Chen, C. Liang, W. Pao

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2590484681

Cites:

Cited by: 1

Related to: 10